CatalystFDA/Bio

Merck/Moderna cancer vaccine cuts melanoma death or recurrence risk by 42%, shares fall - Reuters

Merck/Moderna melanoma vaccine cuts death or recurrence risk over 40%, per Reuters.

What changed

Merck/Moderna melanoma vaccine cuts death or recurrence risk over 40%, per Reuters.

Why it matters

Merck/Moderna melanoma vaccine cuts death or recurrence risk over 40%, per Reuters. — impact context not separately stored; see What changed.

Sources